Vincent Descamps

Prof. Dr. Vincent Descamps

orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in Archives of Dermatology
Verified
Journal Article
Closed access
PDF file
MEMajed Eshki
Majed Eshki
LALaurence Allanore
Laurence Allanore
PMPhilippe Musette
Philippe Musette
BMBrigitte Milpied
Brigitte Milpied
AGAnne Grange
Anne Grange
VDVincent Descamps
Vincent Descamps
Case Report from JAMA Dermatology — Twelve-Year Analysis of Severe Cases of Drug Reaction With Eosinophilia and Systemic Symptoms — A Cause of Unpredictable Multiorgan Failure

1 November 2010 in Annales de Dermatologie et de Vénéréologie
Verified
Journal Article
Closed access
VDVincent Descamps
Vincent Descamps
BSB. Ben Saïd
B. Ben Saïd
BSB. Sassolas
B. Sassolas
FTF. Truchetet
F. Truchetet
MAM. Avenel-Audran
M. Avenel-Audran
ABA. Barbaud
A. Barbaud

1 January 2014 in Joint Bone Spine
Verified
Journal Article
Closed access
VDVincent Descamps
Vincent Descamps
SRSylvie ROGEZ
Sylvie ROGEZ

29 April 2008 in Dermatology
Verified
Journal Article
Open access
PDF file
VDVincent Descamps
Vincent Descamps
JLJennifer Landry
Jennifer Landry
CFCamille Francès
Camille Francès
EMEduardo Marinho
Eduardo Marinho
VRVlad Ratziu
Vlad Ratziu
OCOlivier Chosidow
Olivier Chosidow
Background: Cosmetic filler injections are now a very common procedure for aesthetic purposes. Today no contra-indication is given anymore to any patient for an intradermal filling. Objectives: We draw attention to a possible side effect of facial fillers in a population at risk. Results: We report 2 similar cases of systemic sarcoidosis in patients who both developed a sarcoidal granuloma at the location of a cosmetic filler injection during combined interferon and ribavirin treatment for chronic hepatitis C infection. Cosmetic fillers were hyaluronic acid for one patient and probably silicone for the other. Conclusion: Patients with chronic hepatitis C have a higher risk of interferon-induced sarcoidosis. Physicians must be aware of the risk that a granuloma can develop after a dermal filler injection especially in patients treated with interferon for chronic hepatitis C. These reactions may reveal a systemic sarcoidosis. We propose to perform a test for a hepatitis C virus infection before injecting a dermal filler and to inform the patient of this risk in case of a hepatitis C infection that could necessitate an interferon treatment.

1 December 2006 in Archives of Dermatology
Verified
Journal Article
Open access
PDF file
EMEmmanuelle Matichard
Emmanuelle Matichard
AHAnne Le Hénanff
Anne Le Hénanff
ASAlfred Sanders
Alfred Sanders
JLJocelyne Leguyadec
Jocelyne Leguyadec
BCBeatrice Crickx
Beatrice Crickx
VDVincent Descamps
Vincent Descamps
Melanoma is increasing in most white populations, with the incidence doubling every 10 years.1 Several phenotypic risk factors have been identified, including the number of melanocytic nevi, the presence of dysplastic nevi, a freckling tendency, the propensity for sunburn, and the number of severe sunburn episodes during childhood.2 The strongest risk factor for the development of cutaneous melanoma in white populations is the number of acquired melanocytic nevi.3-6 Most studies found that melanocytic nevi are more common in children with light blue eyes, light skin, and fair hair.7 Sunlight exposure, as measured by sunburn history and exposure, particularly during vacations and on weekends, is one of the major factors in the development of nevi. The pattern and timing of solar exposure are probably important, and many authors have proved that early exposure, before age 15 years, is associated with later development of melanoma.8 Irradiation with visible spectral regions could have a role in human beings similar to that in the animal model of tropical fish of the genus Xiphophorus, in which irradiation with light energy (wavelength >320 nm, including UV-A and visible spectral regions) very early and often in life induced melanomas.9

1 October 2020 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
GBGilles Battesti
Gilles Battesti
JKJihane El Khalifa
Jihane El Khalifa
NANour Abdelhedi
Nour Abdelhedi
VFValentine Ferre
Valentine Ferre
FBFabrice Bouscarat
Fabrice Bouscarat
VDVincent Descamps
Vincent Descamps